Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04349735
Other study ID # Inhalation technique 2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 10, 2019
Est. completion date December 30, 2022

Study information

Verified date February 2023
Source Medical University of Warsaw
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A significant percentage of patients with asthma and COPD do not use their inhalers properly. Experts recommend that in patients with obstructive lung diseases, inhalation technique and patient adherence should be evaluated at every visit. The assessment of inhalation skills depends on the method of evaluation. There are few different methods of assessment of inhalation technique, however none of them is recommended as the most accurate. Therefore, the aim of the study is: 1. to compare three different methods of assessment of inhalation technique in patients with asthma and COPD. These methods include: 1. Checklist of mistakes in inhalation technique (including critical mistakes) 2. 4 grade scale of inhalation technique 3. Assessment by Vitalograph®AIM (Aerosol Inhaling Monitor) 2. to analyze the influence of Vitalograph®AIM based inhalation technique training on inhalation skills One hundred and thirty patients with asthma or COPD, who use inhaled medication on a regular basis will be enrolled. Inhalation technique will be evaluated by two observers independently at the same time with all three methods (checklist, 4 grade scale, Vitalograph®AIM). To compare these methods, the investigators will analyze method reliability and validity. Additionally, inhalation technique will be evaluated 30 minutes after Vitalograph®AIM based training to analyze the potential benefit of its application in practicing inhalation skills.


Description:

Asthma and chronic obstructive pulmonary disease (COPD) are common respiratory diseases. Inhaled therapy is the cornerstone of treatment in these two diseases. However, a significant proportion of patients with asthma and COPD do not use their inhalers properly. Experts recommend that in patients with obstructive lung diseases, inhalation technique and patient adherence should be evaluated at every visit, particularly before introducing changes to the patient's inhalation therapy. The assessment of inhalation skills depends on the method of evaluation. There are few different methods of assessment of inhalation technique, however, none of these methods is recommended as the most accurate. Therefore, the aim of the study is: 1. to compare three different methods of assessment of inhalation technique in patients with asthma and COPD. These methods include: 1. Checklist of mistakes in inhalation technique (including critical mistakes) 2. 4 grade scale of inhalation technique 3. Assessment by Vitalograph®AIM (Aerosol Inhaling Monitor) 2. to analyze an influence of using Vitalograph®AIM based inhalation technique training on inhalation skills. Type of study: prospective, interventional, without randomization. Patients with asthma or COPD treated in hospital or in an out-patient clinic will be asked to participate in the study. Study design One hundred and thirty patients with asthma or COPD, who use inhaled medication on a regular basis will be enrolled. Inhalation technique will be evaluated by two observers independently at the same time with all three methods (checklist, 4 grade scale, Vitalograph®AIM). To compare these methods, the investigators will analyze method reliability and validity. The reference assessment will be performed by two experienced pulmonologists. Additionally, inhalation technique will be evaluated 30 minutes after Vitalograph®AIM based training to analyze the potential benefit of its application in practicing inhalation skills. Outcomes 1. Comparison of three different methods of assessment of inhalation technique in patients with asthma and COPD (reliability, validity and accuracy) 2. Difference in the number of mistakes made during inhalation before and after the Vitalograph® AIM based training. Investigators expect that results of this study will allow to identify the most accurate method for assessment of inhalation technique. Furthermore, the impact of Vitalograph®AIM based training on inhalation skills will be assessed..


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date December 30, 2022
Est. primary completion date October 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion criteria: - informed consent for participating in the study - age 18-85 years - COPD or asthma diagnosed at least 3 months prior to enrollment - using of at least one inhaler regularly every day - using one of the inhalers: Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI) or Metered Dose Liquid Inhalers (MDLI) Exclusion criteria: - lack of informed consent - age <18 years or > 85 years - diagnosis of asthma or COPD not earlier than 3 months before enrollment - using inhalers irregularly. - symptoms of infection 5 days prior to beginning of the study - comorbidity that could prevent patient from using Vitalograph®AIM to teach patient proper inhalation technique (i.e. advanced cognitive disorders, mental diseases, crucial neurological, vision or hearing disorders).

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Assessment of inhalation technique
Assessment of inhalation technique by 3 methods in every patient

Locations

Country Name City State
Poland Department of Internal Medicine, Pneumonology and Allergology, Medical University of Warsaw Warsaw

Sponsors (1)

Lead Sponsor Collaborator
Medical University of Warsaw

Country where clinical trial is conducted

Poland, 

References & Publications (4)

Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P, Everard ML, Horvath I, Navalesi P, Voshaar T, Chrystyn H; European Respiratory Society; International Society for Aerosols in Medicine. What the pulmonary specialist should know about the — View Citation

Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, Serra M, Scichilone N, Sestini P, Aliani M, Neri M; Gruppo Educazionale Associazione Italiana Pneumologi Ospedalieri. Inhaler mishandling remains common in real life and is associated with redu — View Citation

Sanchis J, Gich I, Pedersen S; Aerosol Drug Management Improvement Team (ADMIT). Systematic Review of Errors in Inhaler Use: Has Patient Technique Improved Over Time? Chest. 2016 Aug;150(2):394-406. doi: 10.1016/j.chest.2016.03.041. Epub 2016 Apr 7. — View Citation

Usmani OS, Lavorini F, Marshall J, Dunlop WCN, Heron L, Farrington E, Dekhuijzen R. Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes. Respir Res. 2018 Jan 16;19(1):10. doi: 10.1186/s12931-017-0710-y. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of reliability of assessment of inhalation technique by checklist method in patients with asthma and COPD Assessment of reliability of checklist method measured by 2 observers by kappa Cohen coefficient baseline
Primary Comparison of reliability of assessment of inhalation technique by 4 grade scale in patients with asthma and COPD Assessment of reliability of 4 grade scale measured by 2 observers by kappa Cohen coefficient baseline
Primary Comparison of validity of assessment of inhalation technique by checklist method in patients with asthma and COPD Assessment of validity of checklist method measured by convergence between observer and an expert baseline by kappa Cohen coefficient baseline
Primary Comparison of validity of assessment of inhalation technique by 4 grade scale in patients with asthma and COPD Assessment of validity of 4 grade scale measured by convergence between observer and an expert baseline by kappa Cohen coefficient baseline
Primary Comparison of validity of assessment of inhalation technique by Vitalograph®AIM in patients with asthma and COPD Assessment of validity of Vitalograph®AIM method (convergence between assessment of Vitalograph®AIM and an expert) 30 minutes from baseline
Secondary Utility of Vitalograph® AIM in inhalation technique training Difference in number of inhalation mistakes before and after Vitalograph® AIM based training baseline and in 30 minutes
Secondary Comparison of repeatability of assessment of inhalation technique by checklist method in patients with asthma and COPD Assessment of reliability of checklist method measured by 1 observer baseline and in 30 minutes by kappa Cohen coefficient baseline and in 30 minutes
Secondary Comparison of repeatability of assessment of inhalation technique by 4 grade scale in patients with asthma and COPD Assessment of reliability of 4 grade scale measured by 1 observer baseline and in 30 minutes by kappa Cohen coefficient baseline and in 30 minutes
See also
  Status Clinical Trial Phase
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device